Editor's note: Seeking Alpha is proud to welcome Sergey Chitsvarin as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » sturti/E+ via Getty Images Introduction TransMedics Group, Inc. ( TMDX ) is revolutionizing the...
Editor's note: Seeking Alpha is proud to welcome Sergey Chitsvarin as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » sturti/E+ via Getty Images Introduction TransMedics Group, Inc. ( TMDX ) is revolutionizing the organ transport market with their technology and logistics and is now expanding their business to the largest organ transplant market in the US making it one of the most compelling opportunities in the MedTech sector. Moreover, the recent sell off due to slight margin pressures can be viewed as a good opportunity to buy a strong stock at a cheaper price since TransMedics' business remains largely unaffected and continues to outperform its competitors such as XVIVO (OTCMKTS:XVIPF). TransMedics Group is rapidly growing and maintaining its dominance heading into 2026 and 2027 based on its moat in technology and logistics making it a strong buy. Background To understand TransMedics and their competitive advantage, we need to review their Organ Care System ( OCS ) and the National OCS Program (NOP). OCS is the technology TMDX uses to preserve organs during transport instead of the traditional icebox, which has been the industry standard since the late 1960s. The OCS technology keeps organs in a living, functioning state during transport, which not only increases the chances of a successful transplant but also allows for transplant of organs donated after circulatory death (DCD). Donor Organ Utilization Comparison between TransMedics OCS technology and traditional cold storage. (Source: TransMedics Group Inc. Clinical Trial Data (OCS Lung EXPAND Trial, OCS Heart EXPAND Trial, OCS DCD Heart Trial)) The National OCS Program (NOP) is TransMedics’ end-to-end organ retrieval and transport service which includes their own clinical teams, a fleet of 22 aircraft representing 80% of air ...
TexBr/iStock via Getty Images When investors look at insurers, they often see large balance sheets, generous dividends, and stable businesses. At first, Intact Financial ( IFCZF )( IFC:CA ), Great-West Lifeco ( GWLIF )( GWO:CA ), Manulife ( MFC )( MFC:CA ), and Sun Life ( SLF )( SLF:CA ) look like they belong in the same bucket. But when digging deeper, there are differences to consider. These fou...
TexBr/iStock via Getty Images When investors look at insurers, they often see large balance sheets, generous dividends, and stable businesses. At first, Intact Financial ( IFCZF )( IFC:CA ), Great-West Lifeco ( GWLIF )( GWO:CA ), Manulife ( MFC )( MFC:CA ), and Sun Life ( SLF )( SLF:CA ) look like they belong in the same bucket. But when digging deeper, there are differences to consider. These four insurers don’t grow the same way, they don’t take the same risks, and they won’t appeal to the same type of investor. One dominates property and casualty insurance with disciplined underwriting. One leans more toward steady retirement and wealth businesses. One offers more upside through Asia. One has built a more balanced platform across insurance, group benefits, and asset management. On the surface, they all look solid. Under the hood, each has a very different personality. That’s why this is such a useful stock battle. It’s not really about finding a “perfect” insurer. It’s about understanding which one fits your portfolio best. If we turn this into a ranking of the best Canadian insurance stocks for dividend growth investors, this is where I land: Intact Financial first, Sun Life second, Great-West Lifeco third, and Manulife fourth. That ranking reflects the full picture: business model, earnings resilience, growth profile, and how comfortably each insurer fits inside a long-term dividend growth portfolio. Four Insurers, Four Different Engines All four companies operate in financial services, but they don’t rely on the same models. Intact Financial is the one that stands out from the list. While the others are mostly tied to life insurance, wealth, and retirement products, Intact is a property and casualty insurer. It operates across Canada, the U.S., and the U.K./Ireland through brokers, direct-to-consumer brands like Belairdirect, and commercial platforms. This is a business built on underwriting discipline, claims management, pricing accuracy, and risk selection. ...
Recent European quarter-final was a classic and champions’ Prem trip to the Midlands will likely produce similar Was this the greatest game ever played, people were asking in the aftermath of that quarter-final of the Champions Cup a fortnight ago in Bath. Victory by the odd try in 11; home team roared on to successful comeback victory with that 11th try in the last five minutes; Northampton, the ...
Recent European quarter-final was a classic and champions’ Prem trip to the Midlands will likely produce similar Was this the greatest game ever played, people were asking in the aftermath of that quarter-final of the Champions Cup a fortnight ago in Bath. Victory by the odd try in 11; home team roared on to successful comeback victory with that 11th try in the last five minutes; Northampton, the away team, 28-7 up after barely 20 minutes, playing rugby of the gods. A personal opinion is that it certainly was the greatest game ever played … this month. Without wanting to prick any bubbles of enthusiasm that may have swelled in the moments after the latest epic, yes, the match was incredible – and if it had happened in the amateur era would have been consecrated as legend long ago – but have we already forgotten France v England not even a month earlier? What about Scotland v France a week before that? We could go on. Continue reading...
Protesters gathered in Tokyo on Friday to rally against Japan’s decision to ease decades-old arms export curbs, which critics argue erode the country’s post-war pacifist tradition. The new rules permitting the sale of lethal weapons overseas signal a major shift, as Japan ramps up its defence ambitions and seeks to enter the global arms market in part to boost economic growth. The move, announced ...
Protesters gathered in Tokyo on Friday to rally against Japan’s decision to ease decades-old arms export curbs, which critics argue erode the country’s post-war pacifist tradition. The new rules permitting the sale of lethal weapons overseas signal a major shift, as Japan ramps up its defence ambitions and seeks to enter the global arms market in part to boost economic growth. The move, announced this week on Tuesday by Prime Minister Sanae Takaichi’s government, has been met with some criticism...
A new chapter in the Bugatti story begins today. Twenty-eight years after bringing the storied luxury brand back from the dead, Volkswagen Group no longer counts Bugatti among its stable of brands. Porsche, which became the VW Group steward of Bugatti in 2021 , is selling its stake to a consortium of investors. Bugatti dates back to 1909, when its eponymous founder Ettore Bugatti started making ca...
A new chapter in the Bugatti story begins today. Twenty-eight years after bringing the storied luxury brand back from the dead, Volkswagen Group no longer counts Bugatti among its stable of brands. Porsche, which became the VW Group steward of Bugatti in 2021 , is selling its stake to a consortium of investors. Bugatti dates back to 1909, when its eponymous founder Ettore Bugatti started making cars in the Alsace region contested by France and Germany. That incarnation lasted through two world wars but was gone by 1963. The supercar boom of the late 1980s brought Bugatti back for the first time with the high-tech EB110, a car that combined a carbon fiber monocoque built by Aérospatiale (now better known as Airbus) with an F1-sized V12 (with four turbochargers) and all-wheel drive. As spectacular as that sounds , the twin threats of the even more superlative McLaren F1 and an economic downturn saw it fizzle out in the mid-'90s. The Bugatti you know now returned in 1998, one of a number of projects of Ferdinand Piech , who was then boss of VW Group. Piech wanted to show off the superiority of VW Group's engineering. One project was an ultra-streamlined commuter car , the XL1. Another was the Bugatti Veyron, a hand-built mid-engined two-seater with a thousand metric horsepower and manners so docile his grandmother could drive it to the opera. Read full article Comments
HCA Healthcare ( HCA ) declares $0.78/share quarterly dividend , in line with previous. Forward yield 0.71% Payable June 30; for shareholders of record June 16; ex-div June 16. See HCA Dividend Scorecard, Yield Chart, & Dividend Growth. More on HCA Healthcare HCA Healthcare's Health Check-Up Reveals Opportunity As Earnings Near HCA Healthcare, Inc. (HCA) Presents at 2026 KeyBanc Capital Markets He...
HCA Healthcare ( HCA ) declares $0.78/share quarterly dividend , in line with previous. Forward yield 0.71% Payable June 30; for shareholders of record June 16; ex-div June 16. See HCA Dividend Scorecard, Yield Chart, & Dividend Growth. More on HCA Healthcare HCA Healthcare's Health Check-Up Reveals Opportunity As Earnings Near HCA Healthcare, Inc. (HCA) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript HCA Healthcare, Inc. (HCA) Presents at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Transcript HCA Healthcare slips as lower volumes impact Q1 2026 results HCA Healthcare Non-GAAP EPS of $7.15 in-line, revenue of $19.10B beats by $30M
Guido Mieth/DigitalVision via Getty Images A reader asked for my thoughts on the iShares Ultra Short Duration Bond Active ETF ( ICSH ). ICSH invests in ultra-short-duration bonds with strong credit quality and a duration of only 0.6 years. It is closer to T-bills than to bonds, with a marginal increase in volatility and a slight increase in dividends, with a 4.4% TTM dividend yield and a 4.1% yiel...
Guido Mieth/DigitalVision via Getty Images A reader asked for my thoughts on the iShares Ultra Short Duration Bond Active ETF ( ICSH ). ICSH invests in ultra-short-duration bonds with strong credit quality and a duration of only 0.6 years. It is closer to T-bills than to bonds, with a marginal increase in volatility and a slight increase in dividends, with a 4.4% TTM dividend yield and a 4.1% yield to maturity. ICSH is a buy and should be of particular interest to more risk-averse investors looking for cash or cash plus ETFs. ICSH - Overview and Analysis Strategy and Portfolio ICSH is an actively-managed ETF focusing on ultra-short-term investment-grade bonds and securities. It is explicitly not a money market fund, but it's closer to that than to more traditional bond ETFs, as evidenced by its portfolio. ICSH Considering the above, ICSH's characteristics, fundamentals, and performance should all be quite close to those of T-bills. Specifically, expect little in credit or rate risk, overall volatility, and for dividend yields to (roughly) track Federal Reserve rates. Dividend Yield and Performance ICSH's investments should trade at a slight positive spread to T-bills simply because these are the safest, highest-quality assets in the world, and everything else gets priced at a spread to these, at least everything denominated in dollars. ICSH currently trades with a 4.4% dividend yield, higher than the 4.0% dividend yield of the State Street SPDR Bloomberg 1-3 Month T-Bill ETF ( BIL ), the largest T-bills ETF in the market. Slightly wider spreads for SEC yields: 4.1% for ICSH and 3.5% for BIL, comparable to yield to maturities of 4.1% for ICSH and 3.7% for BIL. Results here are as expected, with the small differences in spreads being likely due to standard ETF dividend volatility. ICSH almost always trades at a positive spread to BIL, as expected. Exceptions are few and far between, sometimes due to timing, sometimes due to standard dividend volatility. Data by YChart...